(DIN INDKøBSKURV / Gå TIL KASSEN):
Bonus: 2
Produkter: 0
Pris: $0.00
|
| HJEMMESIDE | OM OS | ORDRESTATUS | OSS | KONTAKT OS | VIDNESBYRDER | DIN INDKøBSKURV |
|
|
Generic Natdac (Tenofovir disoproxil / daclatasvir / sofosbuvir)Natdac is an oral antiviral medication used to treat chronic hepatitis C infection by inhibiting viral replication and reducing viral load.
|
|
60mg
28piller |
|
$329.99 $274.99 $9.82 pr pille |
+ Gratis standard luftfragt + Forsikring på pakke levering + 10% rabat på fremtidige ordrer |
TILFøJ TIL KURV spar: $0.00 |
|
|
60mg
56piller |
|
$495.59 $412.99 $7.37 pr pille |
+ Gratis standard luftfragt + Forsikring på pakke levering + 10% rabat på fremtidige ordrer |
TILFøJ TIL KURV spar: $137.20 |
| Din ordre |
I dag
29
March
|
leveringsperioden
Sun
29
Mar
Mon
30
Mar
Tue
31
Mar
Wed
01
Apr
Thu
02
Apr
Fri
03
Apr
Sat
04
Apr
Sun
05
Apr
Mon
06
Apr
Tue
07
Apr
Wed
08
Apr
Thu
09
Apr
Fri
10
Apr
Sat
11
Apr
leveringsperioden
Sun
29
Mar
Mon
30
Mar
Tue
31
Mar
Wed
01
Apr
Thu
02
Apr
Fri
03
Apr
Sat
04
Apr
Sun
05
Apr
Mon
06
Apr
|
| Land | Leveringsmetode | Leveringstiden | Pris | |
|
|
Levering |
14-21 dage | 10$ | Sporing # tilgængelig i 4 dage |
Levering |
9-14 dage | 30$ | Sporing # tilgængelig i 2 dage |
![]() |
Forsendelse til hele verden | ![]() |
Fortrolighed og anonymitet er garanteret |
![]() |
Trygt og sikkert | ![]() |
Diskret indpakning |
![]() |
Forsendelse af ordrer inden for 24 timer | ![]() |
100% levering success |
Natdac combines sofosbuvir, daclatasvir, and tenofovir disoproxil to treat chronic hepatitis C virus (HCV) infection, particularly genotypes 1–6. It works by targeting different stages of the viral life cycle, inhibiting viral RNA polymerase and other viral enzymes, which helps to clear the infection and prevent liver damage.
Natdac is taken orally, usually once daily, with or without food, as directed by your healthcare provider. Swallow tablets whole; do not crush or chew. The duration of treatment depends on the type of hepatitis C infection, previous treatment history, and presence of liver complications. Regular monitoring of liver function and viral load is recommended.
Inform your doctor if you have kidney or liver disease, HIV infection, or other chronic illnesses. Monitor for signs of fatigue, jaundice, or unusual bleeding. Avoid alcohol or other hepatotoxic substances during treatment.
Do not use Natdac if allergic to sofosbuvir, daclatasvir, tenofovir disoproxil, or any component of the tablet. It is contraindicated in severe liver impairment or if used with certain medications that interact with the drug components.
Common side effects include headache, fatigue, nausea, diarrhea, and insomnia. Rare but serious side effects may include liver toxicity, severe allergic reactions, or heart rhythm disturbances. Seek medical attention if severe symptoms occur.
Natdac may interact with amiodarone, rifampin, certain anticonvulsants, and other medications affecting liver enzymes. Inform your doctor of all prescription drugs, over-the-counter products, and supplements you are taking.
If a dose is missed, take it as soon as you remember. Do not take extra doses to make up for a missed dose. Continue the regular schedule.
Overdose may cause nausea, vomiting, fatigue, or liver enzyme abnormalities. Seek immediate medical attention if overdose is suspected.
Store Natdac at room temperature, away from heat, moisture, and direct sunlight. Keep tablets in the original container and out of reach of children.
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.